Becker DJ, French B, Morris PB, Silvent E, Gordon RY. Phytosterole, roter Hefereis und Lebensstiländerungen anstelle von Statinen; eine randomisierte, doppelblinde, placebokontrollierte Studie. Am Heart J. 2013;166(1):187-96.
Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med. 2009;150(12):830-9.
Becker DJ, Gordon RY, Morris PB, Yorko J, Gordon YJ, Li M, Iqbal N. Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial. Mayo Clin Proc. 2008 Jul;83(7):758-64.
Bonovich, K, Colfer H, Davidson M, Dujovne C, Greenspan M, Karlberg R, et al. A Multi-Center, Self-Controlled Study of Cholestin In Subjects With Elevated Cholesterol. American Hear Association. 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Orlando, Fl. März 1999.
Havel R. Dietary supplement or drug? The case of cholestin. Am J Clin Nutr. 1999;69(2):175-176.
Heber D, Yip I, Ashley JM, Elashoff DA, Go VLW. Cholesterinsenkende Effekte eines proprietären chinesischen Rothefe-Reis Nahrungsergänzungsmittels. Am J Clin Nutr. 1999;69:231-236.
Huang CF, Li TC, Lin CC, Liu CS, Shih HC, Lai MM. Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients. Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):438-40.
Li C, Li Y, Hou Z. Toxicity study for Monascus purpureus (red yeast) extract. Information of the Chinese Pharmacology Society. 1995;12(4):12 .
Li C, Zhu Y, Wang Y, Zhu J, Chang J, Kritchevsky D. Monascus Purpureus-Fermented Rice (Red Yeast Rice): Ein natürliches Lebensmittelprodukt, das den Cholesterinspiegel im Tiermodell der Hypercholesterinämie senkt. Nutrition Research. 1998;18(1):71-81.
Li Y, Jiang L, Jia Z, et al. A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. PLoS One. 2014;9(6):e98611.
Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fønnebø V. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chin Med. 2006 Nov 23;1:4.
Ma J, Li Y, Ye Q, Li J, Hua Y, Ju D, et al. Constituents of red yeast rice, a traditional Chinese food and medicine. J Agric Food Chem. 2000;48:5220-5225.
Mark D. All red yeast rice products are not created equal. The Am J of Cardiol. 106(3).
Mueller PS. Symptomatische Myopathie aufgrund von rotem Hefereis. Ann Intern Med. 2006;145(6):474-5.
Ong HT, Cheah JS. Statin-Alternativen oder nur Placebo: eine objektive Überprüfung von Omega-3, rotem Hefereis und Knoblauch in der kardiovaskulären Therapie. Chin Med J (Engl). 2008 Aug 20;121(16):1588-94.
Qin S, Zhang W, Qi P, Zhao M, Dong Z, Li Y , et al. Elderly patients with primary hyperlipidemia benefited from treatment with a Monacus purpureus rice preparation: Eine placebokontrollierte, doppelt verblindete klinische Studie. Amerikanische Herzgesellschaft. 39th Annual conference on Cardiovascular Disease Epidemiology and Prevention, Orlando, Fl. März 1999.
Shamim S, Al Badarin FJ, DiNicolantonio JJ, Lavie CJ, O’Keefe JH. Roter Hefereis bei Dysipidämie. Mo Med. 2013;110(4):349-54.
Wang J, Lu Z, Chi J, Wang W, Su M, Kou W, et al. Multicenter clinical trial of serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Curr Ther Res. 1997;58(12):964-978.
Venero C, Venero J, Wortham D, Thompson P. Lipid-lowering efficacy of red yeast rice in a population intolerant to statins. Am J Cardiol. 2010;105(5):664-6.
Vercelli L, Mongini T, Olivero N, Rodolico C, Musumeci O, Palmucci L. Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment. J Am Geriatr Soc. 2006;54(4):718-20.